23181/34347US=47 / Câncer
Klein C, Vassilev LT. Targeting the p53/MDM2 pathway for cancer therapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 19-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

SEGMENTACAO DA VIA P53/MDM2; TERAPIA DE CANCER; PROTEINA P53; MDM2; SUPRESSOR DE TUMOR; INTERACAO PROTEINA-PROTEINA; INTERACAO P53-MDM2

23182/34347US=47 / Câncer
Bender RP, Osheroff N. DNA topoisomerases as targets for the chemotherapeutic treatment of cancer. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 57-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

TOPOISOMERASES DE DNA; CANCER. TERAPIA; QUIMIOTERAPIA; TOPOISOMERASE II; TOPOISOMERASE IIALFA; TOPOISOMERASE IIBETA; TOPOISOMERASE II POISONS; FARMACOS ANTICANCERIGENOS; GENOTOXICIDADE; LEUCEMIA; DNA SUPERCOILING; LESAO DNA

23183/34347US=47 / Câncer
Ackermann JM, El-Deiry WS. Targeting ATM/ATR in the DNA damage checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 93-116. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

SEGMENTACAO ATM/ATR; DANOS AO DNA; ATAXIA TELANGIECTASIA; RADIACAO IONIZANTE; FOSFORILACAO

23184/34347US=47 / Câncer
Kawabe T. Compounds that abrogate the G2 checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 117-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

CICLO CELULAR; G1; G2; ONCOGENESE; TERAPIA DO CANCER; DANOS AO DNA; REPARO DO DNA; MUTACAO

23185/34347US=47 / Câncer
Yap TA, Molife LR, Bono JS. CDK inhibitors as anticancer agents. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 135-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

INIBIDORES DE CDK; AGENTES ANTICANCERIGENOS; CICLO CELULAR; CICLINA DEPENDENTE DE QUINASE; CICLINA; INIBIDOR; FLAVOPIRIDOL; UCN-01; E7070; SELICICLIB; BMS 387032; ZD 304709

23186/34347US=47 / Câncer
Toyota M, Kashima L, Tokino T. CHFR as a potential anticancer target. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 163-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

CHFR; AGENTE ANTICANCERIGENO; CHECKPOINT MITOTICO; CHECKPOINT PROFASE; TUBULINA; UBIQUITINA LIGASE E3; MITOSE

23187/34347US=47 / Câncer
Villalona-Calero MA, Schaaf L, Turowski R. Antimicrotubule agents. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 177-205. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

AGENTES ANTIMICROTUBULOS; TUBULINA; ALCALOIDES DA VINCA; TAXANOS; EPOTILONAS; RESISTENCIA TUMOR; ALBUMINA

23188/34347US=47 / Câncer
Sarli V, Giannis A. Kinesin motor inhibitors as effective anticancer drugs. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 207-26. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

INIBIDORES KINESIN; DROGAS ANTICANCER; KINESINAS; ANTIMITOTICOS; EG5 HUMANA

23189/34347US=47 / Câncer
Kang J, Yu H. Targeting the spindle checkpoint in cancer chemotherapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 227-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

SEGMENTACAO DO CHECKPOINT MITOTICO; QUIMIOTERAPIA; MITOSE; SEGREGACAO DOS CROMOSSOMOS; CHECKPOINT MITOTICO; ANEUPLOIDIA; ANAFASE; UBIQUITINACAO; ANTIMITOTICOS; MAD2; CDC20; BUB1

23190/34347US=47 / Câncer
Shakalya K, Mahadevan D. Antiproliferation inhibitors targeting aurora kinases. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 243-69. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

INIBIDORES ANTI-PROLIFERACAO; AURORA QUINASE; MITOSE; CICLO CELULAR; PROTO-ONCOGENES; INIBIDORES DA PROTEINA-QUINASE; ANEUPLOIDIA; CITOCINESE

23191/34347US=47 / Câncer
Dai W, Yang Y, Jiang N. Plks as novel targets for cancer drug design. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 271-90. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

PLKS; MEDICAMENTO ANTICANCER; POLO-LIKE QUINASES; PLK1; MITOSE; INIBIDORES; DROGAS ANTI-CANCER; FOSFORILACAO

23192/34347US=47 / Câncer
Gabrielli B, Stevens F, Beamish H. Do histone deacetylase inhibitors target cell cycle checkpoints that monitor heterochromatin structure?. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 291-309. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

INIBIDORES DAS HISTONAS DESACETILASES; CONTROLE DO CICLO CELULAR; HETEROCROMATINA; LETALIDADE SINTETICA; PASSAGEIROS CROMOSSOMICOS

23193/34347US=44 / Gastro
Dellon ES, Shaheen NJ. Epidemiology of gastroesophageal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 3-13. ISBN 978-1-4051-2783-7.

CANCER GASTROESOFAGICO. EPIDEMIOLOGIA; CANCER DE ESOFAGO. EPIDEMIOLOGIA; ADENOCARCINOMA DE ESOFAGO; CARCINOMA DE CELULAS ESCAMOSAS DO ESOFAGO; ADENOCARCINOMA GASTRICO; NEOPLASIAS GASTRICAS

23194/34347US=44 / Gastro
Anderson MR, Jankowski J. Factors involved in carcinogenesis and prevention. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 14-20. ISBN 978-1-4051-2783-7.

CARCINOGENESE; ESTILO DE VIDA; FATORES DIETETICOS

23195/34347US=44 / Gastro
Lovell M, Bhan C, Jankowski J, McDonald S. Molecular biology of gastroesophageal cancers: the role of mutational analysis in prognosis. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 21-30. ISBN 978-1-4051-2783-7.

CANCER GASTROESOFAGICO; CANCER GASTRICO. BIOLOGIA MOLECULAR; ANALISE MUTACIONAL NO PROGNOSTICO; CANCER ESOFAGICO. BIOLOGIA MOLECULAR; CARCINOMA DE CELULAS ESCAMOSAS ESOFAGICAS; ADENOCARCINOMA ESOFAGICO

23196/34347US=44 / Gastro
Barr H. Squamous cancer of the esophagus. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 114-45. ISBN 978-1-4051-2783-7.

CARCINOMA EPIDERMOIDE DE ESOFAGO; CARCINOMA EPIDERMOIDE DE ESOFAGO. DIANGOSTICO; CARCINOMA EPIDERMOIDE DE ESOFAGO. HISTOPATOLOGIA; CARCINOMA EPIDERMOIDE DE ESOFAGO. ESTADIAMENTO; CARCINOMA EPIDERMOIDE DE ESOFAGO. IMAGEM; CARCINOMA EPIDERMOIDE DE ESOFAGO. TRATAMENTO; CARCINOMA EPIDERMOIDE DE ESOFAGO. QUIMIOTERAPIA; CARCINOMA EPIDERMOIDE DE ESOFAGO. RADIOTERAPIA; CARCINOMA EPIDERMOIDE DE ESOFAGO. ABLACAO; CARCINOMA EPIDERMOIDE DE ESOFAGO. AGENTES FARMACOLOGICOS; CARCINOMA EPIDERMOIDE DE ESOFAGO. PROGNOSTICO

23197/34347US=44 / Gastro
Songun I, van de Velde C. Diffuse gastric cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 146-76. ISBN 978-1-4051-2783-7.

CANCER GASTRICO DIFUSO. DIAGNOSTICO; CANCER GASTRICO DIFUSO. HISTOPATOLOGIA; CANCER GASTRICO DIFUSO. IMAGEM; CANCER GASTRICO DIFUSO. ESTADIAMENTO; CANCER GASTRICO DIFUSO. TRATAMENTO; CANCER GASTRICO DIFUSO. QUIMIOTERAPIA; CANCER GASTRICO DIFUSO. RADIOTERAPIA; CANCER GASTRICO DIFUSO. NOVOS AGENTES; CANCER GASTRICO DIFUSO. PROGNOSTICO

23198/34347US=44 / Gastro
Wong BCY. Intestinal gastric cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 177-88. ISBN 978-1-4051-2783-7.

CANCER GASTRICO INTESTINAL. DIAGNOSTICO; CANCER GASTRICO INTESTINAL. IMAGEM; CANCER GASTRICO INTESTINAL. ESTADIAMENTO; CANCER GASTRICO INTESTINAL. TRATAMENTO; CANCER GASTRICO INTESTINAL. PROGNOSTICO

23199/34347US=35-A / Ginecologia
Olive DL, Palter SF. Fisiologia reprodutiva. In: Berek JS. Berek & Novak: tratado de ginecologia. 14ª ed. Rio de Janeiro: Guanabara-Koogan, 2008. p. 122-39. ISBN 85-2771439-6.

FISIOLOGIA REPRODUTIVA; NEUROENDOCRINOLOGIA; HIPOTALAMO; HORMONIOS REPRODUTIVO; SECRECAO DE HORMONIOS HIPOFISARIOS; FISIOLOGIA DO CICLO MESTRUAL

23200/34347US=44 / Gastro
Arber N. Small bowel tumors. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 189-226. ISBN 978-1-4051-2783-7.

TUMORES INTESTINAIS. DIAGNOSTICO; TUMORES INTESTINAIS. EPIDEMIOLOGIA; TUMORES ESTROMAIS GASTROINTESTINAIS; TUMORES NEUROENDOCRINOS; TUMORES INTESTINAIS. TRATAMENTO

Primeira | Anterior | Próxima | Última